Jun 01, 2020
Lilly's Taltz® (ixekizumab) is the First IL-17A Antagonist to Receive U.S. FDA Approval for the Treatment of Non-Radiographic Axial Spondyloarthritis (nr-axSpA)
Apr 29, 2020
UCB's Cimzia is Making Inroads in the Treatment of Axial Disease, with Significant Uptake in Non-Radiographic Axial Spondyloarthritis and a Positive Treatment Halo in Ankylosing Spondylitis
Jan 15, 2020
CIMZIA® (certolizumab pegol) Now Approved in Canada for the Treatment of Non-Radiographic Axial Spondyloarthritis
Nov 19, 2019
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028
Nov 12, 2019
ACR 2019: Lilly Presents Positive New Data from COAST-X, a Phase 3 Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Nov 08, 2019
Lilly Reinforces its Commitment to Rheumatology through Data Showcased at the ACR/ARP Annual Meeting
Oct 24, 2019
Ankylosing Spondylitis; Understanding this Chronic Inflammatory Joint Disorder
Oct 02, 2019
Novartis positive 52-week PREVENT data confirm Cosentyx® efficacy in addressing entire axSpA spectrum
Oct 01, 2019
PatientPoint and Spondylitis Association of America Team Up on Point-of-Care Education Campaign
Aug 30, 2019
Innovent Biologics Study Results of IBI303 in Patients with Ankylosing Spondylitis was Published in "The Lancet Rheumatology"
Aug 26, 2019
Lilly Receives U.S. FDA Approval for Taltz® (ixekizumab) for the Treatment of Active Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)
Aug 01, 2019
Survey Finds More Positive Experiences, Better HCP Relationships When Fewer Doctors Needed to Diagnose Ankylosing Spondylitis
Jun 06, 2019
Lilly to Present New Data and Commitment to Patient-Centered Solutions at the Annual European Congress of Rheumatology
May 02, 2019
Spondylitis Association of America Launches Global Spondyloarthritis Summit to Raise Awareness of Painful Rheumatic Disease
Apr 22, 2019
Lilly Announces Positive Top-Line Results for COAST-X, a 52-Week Placebo-Controlled Study of Taltz® (ixekizumab) in Patients with Non-Radiographic Axial Spondyloarthritis
Mar 28, 2019
FDA approves treatment for patients with a type of inflammatory arthritis
Nov 20, 2018
Self-Administered Autoimmune Injectables (mAbs, Cytokines & Fusion Proteins) Market, 2022
Nov 06, 2018
Global Ankylosing Spondylitis Market and Competitive Landscape 2014-2018 & 2023
Nov 01, 2018
Investigation Report on China's Infliximab (Johnson & Johnson) Market, 2018-2022
Oct 23, 2018
Bimekizumab Showed Sustained Improvements in Both Joint and Skin Outcomes for Psoriatic Arthritis Patients